KOREA UNITED PHARM INC

Identity: Manufacturer (Factory)

Company Introduction:

KOREA UNITED PHARM INC. is a prominent pharmaceutical company headquartered in South Korea. Established in 1987, the company is primarily engaged in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products. This includes prescription drugs, over-the-counter medications, health functional foods, and medical devices.

The company operates its own advanced manufacturing facilities, which are certified to stringent national and international quality standards, such as KGMP (Korea Good Manufacturing Practice). KOREA UNITED PHARM INC. is committed to continuous innovation through robust research and development efforts, with the goal of delivering high-quality and effective healthcare solutions to improve human health. While it engages in global distribution and trade of its products, its fundamental identity and core operations are centered around the production of its own pharmaceutical formulations, thus classifying it as a manufacturer.

Here are some of the products that KOREA UNITED PHARM INC. manufactures or sells:

* Clavulanate Potassium

* Cilastatin Sodium

* Moxifloxacin Hydrochloride

* Levofloxacin

* Meropenem

* Linezolid

* Sitagliptin Phosphate Monohydrate

* Irbesartan

* Olmesartan Medoxomil

* Rosuvastatin Calcium

* Atorvastatin Calcium

* Telmisartan

* Amlodipine Besylate

* Valsartan

* Fimasartan Potassium

* Donepezil Hydrochloride

* Tamsulosin Hydrochloride

* Silodosin

* Bethanechol Chloride

* Glafenine